A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)
NCT06756126
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
AK120
Sponsor
Akeso